Page 9 - Sartorius News Today

How molecular virologists are making strides in SARS-CoV-2 research, and the technology that powers their research

Carl Di Iorio examines Australia's record in the Newmarket feature

DJ Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: DECLARATION RELATIVE

DJ Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: DECLARATION RELATIVE

Sartorius recorded a dynamic start to fiscal 2022, with sales revenue and earnings posting strong double-digit growth rates in the first quarter compared with the prior-year period. Based on its p ...

BERLIN (dpa-AFX) - Sartorius Stedim Biotech (SARTF), a pharmaceutical and laboratory equipment supplier, on Thursday reported a significant surge in income for the first quarter, amidst a rise

This application note from Sartorius highlights how the Cubis ® II balance can use software programs to help create and manage formulations safely and reliably - and how to connect with a database to store results, methods and settings in a central system. 

Announcing a new partnership that will expand single-source, real-time analytics methodologies available to manufacturers.

BERLIN (dpa-AFX) - Sartorius AG (SARTF), a German pharmaceutical and laboratory equipment supplier, said it expects group sales revenue to increase by about 15 percent to 19 percent and an underlying

FTC approved petition from Sartorius Stedim Biotech S.A. to acquire chromatography equipment business of Novasep Process SAS. Sartorius was FTC-approved, when the FTC ordered Danaher Corporation to divest assets as a condition of acquiring General Electric’s biopharmaceutical business.